| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Cepeprubart | SelK-2 | Phase 2 Clinical | Selexys | Asthma; Pulmonary Disease, Chronic Obstructive; Venous Thromboembolism | Details |
| Leiolizumab | AbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268 | Phase 2 Clinical | Altrubio Inc | Arthritis, Psoriatic; Colitis, Ulcerative | Details |
| Neihulizumab | AbGn-168; AbGn-168H; ALTB-168 | Phase 1 Clinical | Altrubio Inc | Arthritis, Psoriatic; Colitis, Ulcerative; Graft vs Host Disease; Plaque psoriasis; Psoriasis | Details |
| SSGJ-617 | SSGJ-617; SSGJ617; 61X; VTX-0811; 617 | Phase 1 Clinical | Verseau Therapeutics Inc | Solid tumours | Details |